It is our pleasure to announce the appointment of Bastiaan de Galan, theme Mitochondrial diseases, as associate professor.
As associate professor he will expand his research for the treatment of complicated diabetes mellitus, in particular hypoglycemia.
Bastiaan de Galan studied Medical School at the University of Amsterdam, where he graduated in 1994. He followed specialist training at the Radboud University Medical Center, and has been a staff internist since 2003. His PhD in 2003 was on 'Hypoglycemia unawareness, pathophysiological and pharmacological aspects'. Bastiaan de Galan was appointed as senior research fellow between 2007 and 2008 at the George Institute for Global Health in Sydney, Australia, working on the ADVANCE study.
Related news items
4,8 million euros for prevention of tuberculosis among people with diabetes in Africa16 July 2019
Reinout van Crevel and Lindsey te Brake have received European funding of 4.8 million euros to lead an international consortium to screen thousands of people with diabetes in Uganda and Tanzania for TB, and investigate the effect and costs of 3 months preventive treatment for TB.read more
Handbook of biomarkers and precision medicine a new publication by Alain van Gool12 July 2019
Alain van Gool published a new handbook on biomarkers and applications in (pre)clinical drug development for precision medicine.read more
Successful Summer School by CMBI, TML and Human Genetics8 July 2019
CMBI, TML and Human Genetics organized a successful Summer School on 'Integrative X-omics Analyses Empowering Personalized Healthcare'.read more
Summer greetings from René Bindels5 July 2019
In this last newsletter before the summer break and before I wish you all a happy holiday, I would like to briefly summarize the first half of 2019 and especially look ahead to the interesting activities that will take place in the second half of the year.read more
Prostate cancer theranostics imaging, surgical guidance, and targeted photodynamic therapy5 July 2019
In Theranostics, Mark Rijpkema and colleagues present the development of a novel multimodal tracer that targets both preoperative imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing prostate cancer.read more